Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | Valuation Score | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $156.88 | $9.60 | 1,533.70% | 392.20x | -55.43x | 84.03x | 5.70x | 7.41x | -$603.00k | -0.01% | $778.64M | 28.68 | $4.09B | 228.35 | |
| TGTX | TG THERAPEUTICS INC | $13.47 | $4.88 | 176.28% | 149.67x | -20.10x | 8.18x | 12.96x | 1.08x | -$31.41M | -1.64% | $160.50M | 1.13 | $2.10B | 80.93 | |
| GMAB | GENMAB A | $28.15 | $21.65 | 30.02% | 29.02x | 17.06x | 7.76x | 4.04x | 0.60x | $1.02B | 5.48% | $4.60B | 6.96 | $16.55B | N/A | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.32 | $43.85 | -33.14% | 13.51x | 7.60x | 3.00x | 3.56x | 0.32x | $219.08M | 12.56% | $466.99M | 7.85 | $1.55B | 6.98 | |
| MDXG | MIMEDX GROUP INC | $6.27 | $5.76 | 8.84% | 15.68x | 125.40x | 2.27x | 6.46x | 0.62x | $24.79M | 3.40% | $142.72M | 1.23 | $887.53M | 27.25 | |
| VNDA | VANDA PHARMACEUTICALS INC | $4.62 | $1.65 | 180.25% | 115.50x | 17.11x | 1.38x | 0.49x | 1.13x | $12.42M | 4.68% | $544.91M | 9.50 | $137.01M | 14.65 | |
| CORT | CORCEPT THERAPEUTICS INC | $22.80 | $16.30 | 39.86% | 22.35x | 16.29x | 4.89x | 4.66x | 0.75x | $126.90M | 5.37% | $506.71M | 4.89 | $2.22B | 20.41 | |
| HALO | HALOZYME THERAPEUTICS INC | $38.57 | $47.87 | -19.44% | 18.11x | 9.45x | 6.14x | 58.37x | 0.37x | $373.28M | 7.33% | $83.81M | 0.64 | $6.27B | 13.88 | |
| RPRX | ROYALTY PHARMA PLC | $28.00 | $41.84 | -33.08% | 11.02x | 6.95x | 5.32x | 1.66x | 0.35x | $2.98B | 23.74% | $10.08B | 22.53 | $22.39B | 16.93 | |
| INCY | INCYTE CORP | $51.68 | $63.97 | -19.22% | 19.36x | 8.70x | 3.13x | 2.24x | 0.37x | $464.00M | 4.02% | $5.19B | 23.21 | $8.42B | 9.16 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $80.91 | $37.26 | 117.13% | 74.23x | 28.79x | 6.18x | 3.03x | 0.91x | $191.82M | 1.26% | $5.07B | 26.87 | $15.70B | 43.64 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $109.46 | $183.41 | -40.32% | 16.71x | 4.51x | 1.81x | 1.83x | 0.26x | $1.07B | 15.42% | $3.74B | 59.05 | $11.09B | 9.07 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.76 | $40.38 | -95.64% | 2.41x | 0.57x | 0.31x | 0.28x | 0.02x | $10.68M | 9.03% | $433.43M | 6.45 | -$47.39M | -0.86 | |
| EXEL | EXELIXIS INC | $23.70 | $16.22 | 46.08% | 36.46x | 14.72x | 4.12x | 3.17x | 0.66x | $292.86M | 3.88% | $2.26B | 7.12 | $7.11B | 22.78 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $5.02 | $7.14 | -29.73% | 10.91x | 7.97x | 1.00x | 4.53x | 0.38x | $26.87M | 11.35% | $53.44M | 1.13 | $268.90M | 5.66 | |
| TECH | BIO-TECHNE CORP | $64.06 | $22.21 | 188.39% | 45.43x | 26.58x | 8.81x | 5.13x | 1.55x | $225.39M | 2.23% | $1.96B | 12.46 | $10.50B | 28.14 | |
| BNTX | BIONTECH SE | $87.21 | $77.34 | 12.76% | 20.73x | 18.40x | 4.99x | 0.94x | 0.56x | $5.07B | 24.46% | $22.01B | 92.57 | $8.79B | 5.80 | |
| CPRX | CATALYST PHARMACEUTICALS INC | $14.89 | $7.55 | 97.16% | 22.22x | 16.54x | 3.97x | 4.52x | 1.35x | $143.37M | 9.06% | $387.88M | 3.65 | $1.62B | 12.69 | |
| NVO | NOVO NORDISK A S | $126.85 | $19.45 | 552.27% | 46.67x | 52.31x | 16.92x | 36.88x | 9.80x | $12.10B | 2.11% | $15.51B | 3.44 | $573.93B | 34.45 | |
| UTHR | UNITED THERAPEUTICS CORP | $233.85 | $180.11 | 29.84% | 11.11x | 12.12x | 4.70x | 1.84x | 1.27x | $747.60M | 6.83% | $5.98B | 127.88 | $10.50B | 7.57 | |
| REGN | REGENERON PHARMACEUTICALS INC | $883.20 | $266.18 | 231.81% | 23.84x | 21.73x | 7.18x | 3.73x | 4.92x | $3.88B | 4.11% | $25.97B | 243.42 | $96.91B | 20.65 | |
| VRTX | VERTEX PHARMACEUTICALS INC | $397.48 | $89.18 | 345.69% | 28.29x | 29.25x | 10.38x | 5.84x | 11.53x | $3.34B | 3.26% | $17.58B | 68.22 | $93.03B | 20.20 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.